European alliance defining research priorities and roadmaps for radiation protection in radiology, nuclear medicine, and radiation therapy.
EURAMED is a European-level alliance of medical radiation protection stakeholders — covering radiology, nuclear medicine, and radiation therapy — whose core work is translating scientific knowledge into shared research priorities for the field. Rather than running laboratories or clinical trials, they convene experts to define what research the European medical community needs on ionising radiation safety, and then express those needs as strategic research agendas and roadmaps that can guide funding bodies and research consortia. Their 2020-2023 project produced a concrete patient-centered framework and criteria for centers of excellence in radiation protection, giving them a policy-shaping role in the field. As an association, their value lies in representing the collective voice of the medical radiation protection community and providing governance scaffolding for pan-European research coordination.
Both CONCERT and EURAMED rocc-n-roll place radiation protection in medical settings at their center, with EURAMED rocc-n-roll specifically producing a strategic research agenda and roadmap for the field.
EURAMED rocc-n-roll (2020-2023) was explicitly tasked with producing a European strategic research agenda and a transfer framework for medical radiation protection.
CONCERT (2015-2020) was a European Joint Programme for the integration of radiation protection research across multiple domains, and EURAMED participated as a sectoral representative.
EURAMED rocc-n-roll keywords explicitly include patient-centered criteria and criteria for centers of excellence, indicating a quality-standards and accreditation angle.
EURAMED rocc-n-roll keywords span all three major clinical uses of ionising radiation — radiology, nuclear medicine, and radiation therapy — reflecting the alliance's cross-modality mandate.
In the first phase of their H2020 participation (CONCERT, 2015-2020), EURAMED was embedded in a broad radiation protection research integration programme with no sector-specific keywords surfacing — their contribution was likely more governance and community representation than thematic leadership. By their second project (EURAMED rocc-n-roll, 2020-2023), the focus sharpened dramatically into medical applications specifically, with an explicit patient-centered framing and a deliverable-oriented mandate to produce a strategic research agenda and criteria for centers of excellence. The trajectory is clear: from broad participation in a general radiation protection programme toward owning the medical-applications agenda within that broader ecosystem.
EURAMED is moving toward an agenda-setting and standards-definition role in medical radiation protection, making them a natural partner for projects needing clinical legitimacy, policy alignment, or a connection to the European radiation protection research community.
EURAMED has never led an H2020 project — they participate exclusively as partners, which is consistent with an alliance whose role is to represent a community rather than run a research programme. Despite only two projects, they have accumulated 99 unique consortium partners across 28 countries, almost certainly through CONCERT's large joint programme structure, suggesting they are deeply embedded in the European radiation protection network. This makes them a valuable consortium entry point for projects needing broad community buy-in, though organizations seeking a hands-on research executor will need to look elsewhere.
With 99 unique partners across 28 countries from only two projects, EURAMED has an unusually dense network relative to their project volume — a direct consequence of participating in CONCERT, one of the largest European radiation protection joint programmes. Their reach covers essentially all of the EU and associated research countries.
EURAMED fills a specific niche that research institutions and hospitals cannot: they are the pan-European representative voice of the medical radiation protection research community, covering all three clinical domains (radiology, nuclear medicine, radiation therapy) under one umbrella. For a consortium needing to demonstrate that its work is aligned with the community's own priorities — or needing a conduit to dozens of European radiation protection experts — EURAMED provides that legitimacy and connectivity in a single partner. Their roadmap and strategic agenda outputs from EURAMED rocc-n-roll also give them concrete policy-relevant deliverables that distinguish them from purely academic participants.
